N-Methyl-d-Aspartate Receptor – Nitric Oxide Synthase Pathway in the Cortex of Nogo-A-Deficient Rats in Relation to Brain Laterality and Schizophrenia

It has been suggested that Nogo-A, a myelin-associated protein, could play a role in the pathogenesis of schizophrenia and that Nogo-A-deficient rodents could serve as an animal model for schizophrenic symptoms. Since changes in brain laterality are typical of schizophrenia, we investigated whether Nogo-A-deficient rats showed any signs of disturbed asymmetry in cortical N-methyl-d-aspartate (NMDA) receptor–nitric oxide synthase (NOS) pathway, which is reported as dysfunctional in schizophrenia. In particular, we measured separately in the right and left hemisphere of young and old Nogo-A-deficient male rats the expression of NMDA receptor subunits (NR1, NR2A, and NR2B in the frontal cortex) and activities of NOS isoforms [neuronal (nNOS), endothelial (eNOS), and inducible (iNOS) in the parietal cortex]. In young controls, we observed right/left asymmetry of iNOS activity and three positive correlations (between NR1 in the left and NR2B laterality, between NR2B in the right and left sides, and between NR1 in the right side and nNOS laterality). In old controls, we found bilateral decreases in NR1, an increase in NR2B in the right side, and two changes in correlations in the NR1–nNOS pathway. In young Nogo-A-deficient rats, we observed an increase in iNOS activity in the left hemisphere and two changes in correlations in NR1–nNOS and NR2A–eNOS, compared to young controls. Finally, we revealed in old Nogo-A-deficient animals, bilateral decreases in NR1 and one change in correlation between eNOS–iNOS, compared to old controls. Although some findings from schizophrenic brains did not manifest in Nogo-A-deficient rats (e.g., no alterations in NR2B), others did (e.g., alterations demonstrating accelerated aging in young but not old animals, those occurring exclusively in the right hemisphere in young and old animals and those suggesting abnormal frontoparietal cortical interactions in young animals).

[1]  Tyrone D. Cannon,et al.  The Neurodevelopmental Model of Schizophrenia: Updated , 2015 .

[2]  M. Schwab,et al.  Nogo and Nogo receptor: Relevance to schizophrenia? , 2013, Neurobiology of Disease.

[3]  Christian Beste,et al.  Variation in the NMDA receptor 2B subunit gene GRIN2B is associated with differential language lateralization , 2011, Behavioural Brain Research.

[4]  H. Fukuyama,et al.  Age-related cortical thinning in schizophrenia , 2011, Schizophrenia Research.

[5]  D. Řípová,et al.  Aging and Lateralization of the Rat Brain on a Biochemical Level , 2010, Neurochemical Research.

[6]  J. Horáček,et al.  Expression of the Hippocampal NMDA Receptor GluN1 Subunit and Its Splicing Isoforms in Schizophrenia: Postmortem Study , 2010, Neurochemical Research.

[7]  A. Schröter,et al.  Nogo-A Regulates Neural Precursor Migration in the Embryonic Mouse Cortex , 2010, Cerebral cortex.

[8]  J. Feldon,et al.  Constitutive Genetic Deletion of the Growth Regulator Nogo-A Induces Schizophrenia-Related Endophenotypes , 2010, The Journal of Neuroscience.

[9]  P. Emson,et al.  Increased expression of the NR2A NMDA receptor subunit in the prefrontal cortex of rats reared in isolation , 2009, Synapse.

[10]  J. Sutcliffe,et al.  Normal human aging and early‐stage schizophrenia share common molecular profiles , 2009, Aging cell.

[11]  Zeny Z. Feng,et al.  Genetic Variants of Nogo-66 Receptor with Possible Association to Schizophrenia Block Myelin Inhibition of Axon Growth , 2008, The Journal of Neuroscience.

[12]  D. Řípová,et al.  Lateralization of hippocampal nitric oxide mediator system in people with Alzheimer disease, multi-infarct dementia and schizophrenia , 2008, Neurochemistry International.

[13]  Philip D. Harvey,et al.  Is schizophrenia a syndrome of accelerated aging? , 2008, Schizophrenia bulletin.

[14]  M. Fujiki,et al.  Nitric oxide synthase and NMDA receptor expressions in cavernoma tissues with epileptogenesis , 2007, Acta neurologica Scandinavica.

[15]  G. Abecasis,et al.  Nogo Receptor 1 (RTN4R) as a Candidate Gene for Schizophrenia: Analysis Using Human and Mouse Genetic Approaches , 2007, PloS one.

[16]  G. Novak,et al.  Nogo A, B and C expression in schizophrenia, depression and bipolar frontal cortex, and correlation of Nogo expression with CAA/TATC polymorphism in 3′-UTR , 2006, Brain Research.

[17]  V. Haroutunian,et al.  Up‐regulation of NMDA receptor subunit and post‐synaptic density protein expression in the thalamus of elderly patients with schizophrenia , 2006, Journal of neurochemistry.

[18]  I. Ferrer,et al.  Nogo-A Expression in the Human Hippocampus in Normal Aging and in Alzheimer Disease , 2006, Journal of neuropathology and experimental neurology.

[19]  Y. Teo,et al.  Gender-specific association of insertion/deletion polymorphisms in the nogo gene and chronic schizophrenia. , 2005, Brain research. Molecular brain research.

[20]  J L Rapoport,et al.  The neurodevelopmental model of schizophrenia: update 2005 , 2005, Molecular Psychiatry.

[21]  M. Schwab,et al.  Nogo-A, -B, and -C Are Found on the Cell Surface and Interact Together in Many Different Cell Types* , 2005, Journal of Biological Chemistry.

[22]  A. Hobbs,et al.  Resistance to Endotoxic Shock in Endothelial Nitric-oxide Synthase (eNOS) Knock-out Mice , 2005, Journal of Biological Chemistry.

[23]  C. Caltagirone,et al.  Mutations of the Nogo‐66 receptor (RTN4R) gene in schizophrenia , 2004, Human mutation.

[24]  T. Woo,et al.  Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. , 2004, Archives of general psychiatry.

[25]  J. Meador-Woodruff,et al.  Abnormalities of the NMDA Receptor and Associated Intracellular Molecules in the Thalamus in Schizophrenia and Bipolar Disorder , 2004, Neuropsychopharmacology.

[26]  Jan Klaschka,et al.  Age- and Sex-Dependent Laterality of Rat Hippocampal Cholinergic System in Relation to Animal Models of Neurodevelopmental and Neurodegenerative Disorders , 2004, Neurochemical Research.

[27]  Ryosuke Kawakami,et al.  Asymmetrical Allocation of NMDA Receptor ε2 Subunits in Hippocampal Circuitry , 2003, Science.

[28]  Philip D. Harvey,et al.  White matter changes in schizophrenia: evidence for myelin-related dysfunction. , 2003, Archives of general psychiatry.

[29]  Hae-Jeong Park,et al.  Functional disconnection between the prefrontal and parietal cortices during working memory processing in schizophrenia: a[15(O)]H2O PET study. , 2003, American Journal of Psychiatry.

[30]  M. Schwab,et al.  Systemic Deletion of the Myelin-Associated Outgrowth Inhibitor Nogo-A Improves Regenerative and Plastic Responses after Spinal Cord Injury , 2003, Neuron.

[31]  P. Seeman,et al.  Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert. , 2002, Brain research. Molecular brain research.

[32]  A. Young,et al.  Age-related changes in the protein expression of subunits of the NMDA receptor. , 2002, Brain research. Molecular brain research.

[33]  R. Conley,et al.  Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. , 2000, The American journal of psychiatry.

[34]  H. Coon,et al.  Evidence for a chromosome 2p13–14 schizophrenia susceptibility locus in families from Palau, Micronesia , 1998, Molecular Psychiatry.

[35]  T. Crow,et al.  A genome-wide search for schizophrenia susceptibility genes. , 1998, American journal of medical genetics.

[36]  治徳 大介.  Association study of Nogo-related genes with schizophrenia in a Japanese case-control sample , 2011 .

[37]  Lin He,et al.  Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: A HuGE review and meta-analysis , 2007, Genetics in Medicine.

[38]  A. Toga,et al.  Mapping brain asymmetry , 2003, Nature Reviews Neuroscience.

[39]  Filipponi,et al.  Evidence for , 1996, Physical review. B, Condensed matter.